CD44 and neoplasm: Nanocarriers prepared from HA-based amphiphilic block copolymers, including prodrug, dendrimers, or micelles, can not only reduce phagocytosis by the reticuloendothelial system (RES), but also achieve active targeting of tumor cells due to the overexpression of CD44 [91,92,93].